Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer.

Kiviaho A. et al, (2024), Nat Commun, 15

Author Correction: IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling.

Sheng X. et al, (2024), Nat Commun, 15

Metabolic imaging across scales reveals distinct prostate cancer phenotypes

Sushentsev N. et al, (2024), Nature Communications, 15

Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease.

Charlton PV. et al, (2024), Prostate, 84, 977 - 990

Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics.

Desai TA. et al, (2024), EBioMedicine, 105

Adaptations of membrane trafficking in cancer and tumorigenesis.

Evergren E. et al, (2024), J Cell Sci, 137

Identifying proteomic risk factors for cancer using prospective and exome analyses of 1463 circulating proteins and risk of 19 cancers in the UK Biobank.

Papier K. et al, (2024), Nat Commun, 15

CDK9 inhibition activates innate immune response through viral mimicry.

Yalala S. et al, (2024), FASEB J, 38

Systemic interrogation of immune-oncology-related proteins in patients with locally advanced prostate cancer undergoing androgen deprivation and intensity-modulated radiotherapy.

Guldvik IJ. et al, (2024), World J Urol, 42

Intra-prostatic tumour evolution, steps in metastatic spread and histogenomic associations revealed by integration of multi-region whole-genome sequencing with histopathological features.

Rao S. et al, (2024), Genome Med, 16

Peroxisomal β-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostate cancer.

Mah CY. et al, (2024), Br J Cancer

Imaging tumor lactate is feasible for identifying intermediate-risk prostate cancer patients with postsurgical biochemical recurrence.

Sushentsev N. et al, (2023), Proc Natl Acad Sci U S A, 120

Molecular Anatomy of Prostate Cancer and Its Implications in Active Surveillance and Early Intervention Strategies

Figiel S. et al, (2023), Anatomia, 2, 300 - 319

Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures.

Figiel S. et al, (2023), Mol Cancer, 22

Histomic and transcriptomic features of MRI-visible and invisible clinically significant prostate cancers are associated with prognosis.

Lehto T-PK. et al, (2023), Int J Cancer

Identifying proteomic risk factors for overall, aggressive and early onset prostate cancer using Mendelian randomization and tumor spatial transcriptomics.

Desai TA. et al, (2023), medRxiv

Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those withde novometastatic disease

Charlton P. et al, (2023)

Untangling heterogeneity: From complexity to prediction.

Mills IG., (2023), Int J Cancer

Genomic Evolution and Transcriptional Changes in the Evolution of Prostate Cancer into Neuroendocrine and Ductal Carcinoma Types.

Rao SR. et al, (2023), Int J Mol Sci, 24

Identifying proteomic risk factors for cancer using prospective and exome analyses: 1,463 circulating proteins and risk of 19 cancers in the UK Biobank

Papier K. et al, (2023)

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?